Paolo Tarantino
- Oncology top 1%
- HER2/EGFR in Cancer Research 71
- Cancer Treatment and Pharmacology 18
- Cancer Immunotherapy and Biomarkers 15
- CAR-T cell therapy research 14
- Cancer Research top 2%
- Breast Cancer Treatment Studies 28
- Cancer Genomics and Diagnostics 11
-
- Monoclonal and Polyclonal Antibodies Research 36
-
- Advanced Breast Cancer Therapies 32
- Genetics top 10%
Paolo Tarantino
118 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 2.3k
- Cancer Research 777
- Radiology, Nuclear Medicine and Imaging 1000
- Pulmonary and Respiratory Medicine 826
- Genetics 148
Countries citing papers authored by Paolo Tarantino
This map shows the geographic impact of Paolo Tarantino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Tarantino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Tarantino more than expected).
Fields of papers citing papers by Paolo Tarantino
This network shows the impact of papers produced by Paolo Tarantino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Tarantino. The network helps show where Paolo Tarantino may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paolo Tarantino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 4 | |
| 7 | The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Developmentbreakdown → | 2024 | 65 |
| 8 | 2024 | 7 | |
| 9 | 2023 | 21 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 21 | |
| 12 | 2023 | 45 | |
| 13 | 2023 | 16 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 19 | |
| 16 | 2023 | 1 | |
| 17 | 2022 | 41 | |
| 18 | 2021 | 28 | |
| 19 | 2021 | 5 | |
| 20 | 2018 | 88 |
About Paolo Tarantino
Paolo Tarantino is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 128 papers that have together received 3.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (71 papers), Monoclonal and Polyclonal Antibodies Research (36 papers), Advanced Breast Cancer Therapies (32 papers), Breast Cancer Treatment Studies (28 papers), Cancer Treatment and Pharmacology (18 papers), Cancer Immunotherapy and Biomarkers (15 papers), CAR-T cell therapy research (14 papers) and Cancer Genomics and Diagnostics (11 papers). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (777 citations) and Radiology, Nuclear Medicine and Imaging (1000 citations). Paolo Tarantino has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Giuseppe Curigliano, Sara M. Tolaney, Chiara Corti, Stefania Morganti, Dario Trapani, Emanuela Ferraro, Federica Giugliano, Javier Cortés, Fabrice André and Antonio Marra. Their work appears in journals such as ESMO Open, Journal of Clinical Oncology, European Journal of Cancer, Cancer Treatment Reviews and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.